Accession Number: | 0001055726-21-000052 |
Date: | 2021-06-09 |
Issuer: | INOVIO PHARMACEUTICALS, INC. (INO) |
Original Submission Date: |
SHEA JACQUELINE ELIZABETH
660 W. GERMANTOWN PIKE
PLYMOUTH MEETING, PA 19462
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-09 | S | 38,535 | d | $10.01 | 21,592 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | these transactions were executed in multiple trades at prices ranging from $10.00 to $10.06, inclusive. the price reported in column 4 is a weighted average price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |